Evaluation of moxalactam with the BD phoenix system for detection of methicillin resistance in coagulase-negative staphylococci.
H Pupin, H Renaudin, O Join-Lambert, C Bébéar, F Mégraud, P Lehours
Index: J. Clin. Microbiol. 45(6) , 2005-8, (2007)
Full Text: HTML
Abstract
The performance of moxalactam with the BD Phoenix system for the detection of methicillin resistance in coagulase-negative staphylococci was evaluated by use of a collection of 186 strains. Moxalactam was a better drug as an indicator of methicillin resistance for mecA-positive strains than oxacillin and cefoxitin were. For strains other than Staphylococcus saprophyticus, a moxalactam MIC >16 microg/ml was indicative of methicillin resistance.
Related Compounds
Related Articles:
2012-10-01
[Antimicrob. Agents Chemother. 56(10) , 5157-63, (2012)]
2007-04-01
[J. Antimicrob. Chemother. 59(4) , 763-6, (2007)]
2002-02-01
[J. Antimicrob. Chemother. 49(2) , 315-20, (2002)]
1999-06-01
[Am. J. Gastroenterol. 94(6) , 1694-6, (1999)]
2001-07-10
[Biochemistry 40(27) , 7992-9, (2001)]